By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


PDI, Inc. 

Morris Corporate Center 1
Building A
300 Interpace Parkway

Parsippany  New Jersey  07054  U.S.A.
Phone: 862-207-7800 or 800-242-7494 Fax: n/a

PDI, a premier healthcare sales and marketing company, provides strategic alternatives to the portfolio challenges of biopharmaceutical and medical device and diagnostics manufacturers. Focusing on two core businesses, sales and marketing services and product commercialization, PDI leverages its expertise to maximize profitable brand growth.

PDI built its reputation as a market leader delivering innovative solutions, extraordinary service and superior results. Offering four strategic sales force solutions, recruitment services, marketing research, and medical education programs, PDI continues to meet the ever-changing needs of the industry. Deployed independently or in combination, these services leverage our pioneering outsourcing expertise into next-generation sales and marketing services, promoting maximum profitable brand sales growth. PDI also maintains a global presence through a strategic partnership with In2Focus, a leading European outsourced sales company.

Backed by the strength of a comprehensive commercial infrastructure, PDI responds to the needs of clients of all sizes, providing an outsourced infrastructure to small and emerging pharmaceutical manufacturers with limited resources, as well as strategic alternatives for larger manufacturers with products that no longer meet their strategic intent.

For all of its clients and partners, PDI's commitment remains constant: to deliver passion, integrity, innovation, excellent execution and superior results to the biopharmaceutical and medical device and diagnostics industry.

For more information, visit PDI's Website at

Last Updated: 03-30-04

Key Statistics

Ownership: Public

Web Site: PDI, Inc.
Symbol: PDII


Company News
PDI, Inc. (PDII) Release: New Randomized Study Shows 3.15% Chlorhexidine Gluconate/70% Isopropyl Alcohol Solution Most Effective For Disinfecting Needleless Access Sites At 5 Second Scrub Time 10/21/2014 8:53:00 AM
PDI, Inc. (PDII) Announces Appointment Of Graham G. Miao, MBA, Ph.D. As Chief Financial Officer 10/15/2014 7:58:49 AM
New PrevanticsĀ® Device Swab From PDI, Inc. (PDII) Receives FDA 510k Market Authorization 9/9/2014 11:03:08 AM
PDI, Inc. (PDII) Release: Sani ProfessionalĀ® Launches Food Safety Advisory Council 9/9/2014 8:05:45 AM
PDI, Inc. (PDII) Reports 2014 Second Quarter Financial Results 8/14/2014 8:13:16 AM
Molecular Diagnostics (MCDG) Veteran Heiner Dreismann, Ph.D., Joins PDI, Inc. (PDII) Board Of Directors 8/14/2014 8:10:21 AM
PDI, Inc. (PDII) Subsidiary Interpace Diagnostics Enters Molecular Diagnostics Market with Thyroid and Pancreatic Cancer Test Portfolio Acquisition 8/13/2014 2:44:41 PM
PDI, Inc. (PDII) To Hold Second Quarter Financial Results Conference Call On Thursday, August 14, 2014 8/11/2014 8:14:29 AM
PDI, Inc. (PDII) Announces Appointment Of Peter Cempellin And Patrick Treacy To Senior Leadership Roles 7/2/2014 9:25:54 AM
PDI, Inc. (PDII) Sani-HandsĀ® Instant Hand Sanitizing Wipes Deliver 360 Degree Approach to Hand Hygiene 6/19/2014 6:56:16 AM